🔎 Trials Near Me

Utama › COPD › Illinois › Chicago

Kajian klinikal COPD di Chicago, IL

14 kajian untuk COPD sedang mencari peserta di lokasi dalam dan sekitar Chicago (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Mengambil pesertaFasa 3
  • Research Site, Chicago
Umur 40 hingga 80 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Mengambil pesertaFasa 3
  • University of Illinois-Chicago - College of Medicine- Site Number : 8400055, Chicago
Umur 40 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07190209

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Mengambil peserta
  • Northwestern University, Chicago
  • University of Chicago Medical Center, Chicago
Umur 40 hingga 80 · Semua jantina · Dikemas kini 17 Sep 2026 · NCT06035120

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

Mengambil pesertaFasa 2
  • Northwestern University, Chicago
  • Rush University Medical Center, Chicago
Umur 40 ke atas · Semua jantina · Dikemas kini 4 Sep 2026 · NCT07059091

STRIVE Post-Market Registry Study

Mengambil pesertaKajian pemerhatian
  • Northwestern University, Division of Pulmonary and Critical Care Medicine, Chicago
  • University of Chicago, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT04302272

Functional Improvement in OSA and COPD With a Telehealth LifeStyle and Exercise Intervention

Mengambil peserta
  • Jesse Brown VA Medical Center, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 22 Jul 2026 · NCT06390345

A Multi Center Study Testing a New Implant for Adults With Severe Emphysema

Mengambil peserta
  • Northwestern University, Chicago
Umur 22 ke atas · Semua jantina · Dikemas kini 3 Jun 2026 · NCT07119229

SPIROMICS Study of Early COPD Progression (SOURCE)

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • University of Illinois Chicago, Chicago
Umur 30 hingga 55 · Semua jantina · Dikemas kini 3 Jun 2026 · NCT05033990

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Mengambil peserta
  • University of Chicago, Chicago
Umur 40 hingga 84 · Semua jantina · Dikemas kini 24 Apr 2026 · NCT06891755

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Mengambil pesertaFasa 3
  • GSK Investigational Site, Chicago
Umur 40 hingga 80 · Semua jantina · Dikemas kini 9 Apr 2026 · NCT06961214

PiMZ Longitudinal Cohort (PiMZ Logic)

Mengambil pesertaKajian pemerhatian
  • University of Chicago, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 16 Jan 2026 · NCT06505603

COPD Resources, Education, and Activity Designed for You Study

Mengambil peserta
  • Rush University Medical Center, Chicago
Umur 40 ke atas · Semua jantina · Dikemas kini 22 Sep 2025 · NCT07125053

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

Mengambil pesertaKajian pemerhatian
  • University of Chicago, Chicago
Umur 50 ke atas · Semua jantina · Dikemas kini 5 Ogo 2025 · NCT06122077

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Mengambil peserta
  • University of Chicago, Chicago
Umur 30 ke atas · Semua jantina · Dikemas kini 6 Feb 2025 · NCT05204888

Kajian COPD di bandar lain

Kajian lain di Chicago

Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.